| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425562 Inhibitors of cruzipain and other cysteine proteases |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425448 Cells for use as models in the treatment of heart defects |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425326 Degrading collagen within an atherosclerotic plaque in a chronically occluded animal tube or cavity by administering proteolytic enzyme; angioplasty |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2400319C Coating that promotes endothelial cell adherence |
| 09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2356422C Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
| 09/16/2008 | CA2339290C Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 09/16/2008 | CA2331414C Transdermal therapeutic system for the administration of candesartan |
| 09/16/2008 | CA2295483C Aliphatic propargylamines as cellular rescue agents |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/12/2008 | WO2008109856A2 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 09/12/2008 | WO2008109175A1 Deuterated piperazine derivatives as anti-anginal compounds |
| 09/12/2008 | WO2008108486A1 1-biarylazetidinone derivatives |
| 09/12/2008 | WO2008108424A1 Device for the transdermal administration of bisoprolol |
| 09/12/2008 | WO2008108322A2 Composition and method for protecting mitochondria |
| 09/12/2008 | WO2008107211A2 Novel p2y12 receptor antagonists |
| 09/12/2008 | WO2008106863A1 The use of iridoids in the manufacture of the medicine for promoting nerve cell proliferation and differentiation |
| 09/12/2008 | WO2008106821A1 A chinese medicine composition and the extract of worms thereof and their preparation |
| 09/12/2008 | WO2008106772A1 Phospholipid compositions with improved bioavailability and methods for their use |
| 09/12/2008 | WO2008106715A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | WO2008081116A3 Cellular preparations for use as a revascularisation stimulating agent |
| 09/12/2008 | WO2008076245A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 09/12/2008 | WO2008042421A3 Peptides derived from the c2 domain of epsilon pkc, and use thereof |
| 09/12/2008 | WO2008037224A3 Controlled release dosage form containing lercanidipine and a performance enhancing acid |
| 09/12/2008 | CA2679580A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | CA2678424A1 Percutaneous administration device of bisoprolol |
| 09/12/2008 | CA2675312A1 1-biarylazetidinone derivative |
| 09/11/2008 | US20080221225 Genes associated with restenosis |
| 09/11/2008 | US20080221210 3-(3,5-dibromo-4-{[3-(methylamino)benzyl]oxy}phenyl)propanoic acid; hypercholesterolemia, dyslipidemia, obesity, diabetes, atherosclerosis and cardiac diseases |
| 09/11/2008 | US20080221207 Use of specific cyklolignans |
| 09/11/2008 | US20080221203 Use of Agonists and Antagonists of Beta Adrenoceptors for Treating Arterial Disease |
| 09/11/2008 | US20080221197 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221178 Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof |
| 09/11/2008 | US20080221176 treatment of diabetes mellitus, cardiovascular disease, dyslipidemia, artherosclerosis, peripheral vascular disease, inflammation, cancer, and diseases of the central nervous system; 1,1,1,3,3,3-hexafluoro-2-{4-[methyl(phenylmethyl)amino]phenyl}-2-propanol |
| 09/11/2008 | US20080221174 Controlled release nisoldipine compositions |
| 09/11/2008 | US20080221172 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 09/11/2008 | US20080221145 Pyrroloquinoline quinone drugs for treatement of cardiac injury and methods of use thereof |
| 09/11/2008 | US20080221136 Novel Pyrrolo [3,2-D]Pyrimidin-4-One Derivatives And Their Use In Therapy |
| 09/11/2008 | US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants |
| 09/11/2008 | US20080221129 New compounds |
| 09/11/2008 | US20080221123 geranylgeranyltransferase I inhibitors; treatment of neoplasia, hyperproliferative cell growth, psoriasis, intimal hyperplasia (restinosis) and chronic inflammatory diseases including rheumatoid and osteoarthritis |
| 09/11/2008 | US20080221112 New utilities of amide compounds |
| 09/11/2008 | US20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists |
| 09/11/2008 | US20080221101 Calcium receptor modulating agents |
| 09/11/2008 | US20080221100 Soluble epoxide hydrolase inhibitors |
| 09/11/2008 | US20080221092 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221084 Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor |
| 09/11/2008 | US20080221083 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221075 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221053 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
| 09/11/2008 | US20080221044 Composition for Inhibiting the Onset of Arteriosclerosis and Inhibition Method |
| 09/11/2008 | US20080221041 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 09/11/2008 | US20080221038 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221033 Assaying an inactive natriuretic peptide and an active natriuretic peptide from a patient responsive to cardiac stress;administering a therapeutic agent interfering with the active natriuretic peptide assay but not with the inactive natriuretic peptide assay |
| 09/11/2008 | US20080221028 Compositions and Methods for Treating Atherosclerosis |
| 09/11/2008 | US20080221025 Use of Trpc Channel for the Treatment of a Cardiovascular Disease |
| 09/11/2008 | US20080221018 Crystalline solid and amorphous forms of (-)- halofenate and methods related thereto |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | US20080220092 Overcoming active agent tolerance, which may be experienced from continuous administration, improve patient compliance, and in some cases reducing the amount of drug needed per dose due to advantages of biosynchronization |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220057 Therapeutic compounds and methods of use |
| 09/11/2008 | US20080220055 nanostructure particles having functional groups with binding affinity for platelets and endothelial walls, coupled to the surface of the particles, and encapsulating drugs, used for tissue-targeted therapy |
| 09/11/2008 | US20080220051 Powdery Sterol Compositions Containing Colloid-Forming Agents |
| 09/11/2008 | US20080220049 Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219985 Prok2 antagonists and methods of use |
| 09/11/2008 | US20080219980 Bi-Specific Complexes for Targeting Cells Involved in Allergic-Type Reactions, Compositions and Uses Thereof |
| 09/11/2008 | US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967513A1 Novel P2Y12 receptor antagonists |
| 09/10/2008 | EP1966219A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 09/10/2008 | EP1966218A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966217A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 09/10/2008 | EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/10/2008 | EP1966139A1 Aspartic protease inhibitors |
| 09/10/2008 | EP1966130A2 Modified lysine-mimetic compounds |
| 09/10/2008 | EP1965831A2 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 09/10/2008 | EP1965803A1 Methods and compositions for the treatment of disease |
| 09/10/2008 | EP1965796A2 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions |
| 09/10/2008 | EP1965650A2 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 09/10/2008 | EP1868626B1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons |
| 09/10/2008 | EP1685107B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 09/10/2008 | EP1633883B1 Method for assaying lkb1 phosphorylation activity |
| 09/10/2008 | EP1486501B1 Aminomethyl-substituted thiazolobenzimidazole derivative |